WTO

2011: The Year Ahead at WHO, WIPO and WTO

As 2011 unfolds, the following conferences and negotiations are expected to shape the knowledge governance landscape this year at WHO, WIPO and WTO.

    World Health Organization

Paragraph 6 system: Brazilian intervention at the WTO TRIPS Council

On Wednesday, 27 October 2010, Brazil delivered the following intervention during the annual review of the Paragraph 6 system at the WTO TRIPS Council. The Brazilian intervention followed Canada's detailed explanation of her use of the Paragraph 6 system in the Apotex/Rwanda case. The Brazilian intervention voiced concern over the future prospects of access to competitively priced second and third line ARVs raising questions as to whether the Paragraph 6 system would be economically viable for generic producers.

KEI statement on possible WTO disputes against the EU seizures of goods in transit

12 May 2010

Statement of Knowledge Ecology International on possible WTO disputes against the EU seizures of goods in transit

Thiru Balasubramaniam, Geneva Representative

“In a world with territorial patent rights, it is important that the rules for ‘goods in transit’ permit the transport of medicines from places where they can be made to places where they will be used. The EU's systematic seizure of at least 17 drug consignments is indefensible and undermines the very principle of free trade, the raison d’être of the World Trade Organization.

FT on Dutch Seizures of Generic Abacavir

In today’s Financial Times, Andrew Jack, Frances Williams and Michael Steen report on Dutch seizure of generic Abacavir in transit to Africa:

http://www.ft.com/cms/s/0/0a0a0a9e-0928-11de-b8b0-0000779fd2ac.html

Dozens of HIV patients have been placed at risk after the Dutch authorities seized consignments of Indian-made medicines shipped via Schipol airport for distribution to clinics in Nigeria, a multilateral agency yesterday said.

KEI Statement on March 9 letter from Pascal Lamy, regarding Dutch confiscation of medicines in transit to developing countries

Today Pascal Lamy responded to a February 18, 2009 NGO letter that among other things requested he use his office to mediate the dispute regarding the European Union policy of seizing generic medicines that are in transit to developing countries. The original letter and Mr Lamy’s response are available here:

WTO Director General Pascal Lamy’s response to joint NGO letter about seizures of medicines in trasit to developing countries

On 18 February 2009, sixteen NGOs sent a letter to the head of the World Trade Organization regarding a series of seizures by the Dutch custom authorities of generic medicines in transit to developing countries. The letter is available at

http://www.keionline.org/misc-docs/seizures/WTO_seizures_18feb.pdf

Today, Director General Pascal Lamy responded to the letter which is available at

Statement by Brazil at TRIPS Council: Public Health dimension of TRIPS Agreement

On 3 March 2009, the following intervention was delivered by Ambassador Roberto Azevêdo, Permanent Representative of Brazil to the WTO and other economic organizations in Geneva.

_____________________________________________________________________________________________

TRIPS Council
Agenda item ‘M’ – OTHER BUSINESS – Public Health dimension of TRIPS Agreement

Statement by Brazil

Mr. Chairman,

Intervention by Brazil at WTO General Council on seizure of 500 kilos of generic medicines by Dutch customs authorities

On this day, 3 February 2009, H.E. Ambassador Roberto AZEVÊDO, Permanent Representative of Brazil to the World Trade Organization (WTO) and other economic organizations in Geneva made the following intervention at the WTO General Council meeting on the seizure by Dutch authorities of a cargo of 500 kilos of losartan potassium en route from India to Brazil.

The Medical Innovation Prize Fund (S.2210, 110th Congress) and the WTO TRIPS Agreement

I have been asked to elaborate on the relationship between the Medical Innovation Prize Fund (S.2210, 110th Congress) and the WTO TRIPS Agreement.

For centuries, innovation inducement prizes have been suggested as a mechanism to stimulate investments in a wide range of topics. (See, for example, Selected Innovation Prizes and Reward Programs, KEI Research Note 2008:1). During most of this period, the patent system has also existed.

Syndicate content